FROM T.I. (over on the YMB)
"Investor Group
FROM T.I. (over on the YMB)
"Investor Group Goals:
today, I spoke with Paul Rosenbaum, the lead investor in the 13D filing. He has been an investor in Cytodyn for more than 8 years. He feels passionately about the prospects of Cytodyn. He and his group believe that the prospects for success could be substantially enhanced by making changes. They plan to provide investors with proposals for these changes within the next few weeks.
NP is a Bulldog and has made tremendous progress. But to be honest, his prognostications of the time frame for approval and sales have consistently been way, way off. They are so far off that I sometimes wonder how firm a grasp of the regulatory landscape NP really has. After all, he has never achieved an FDA approval or sales anywhere.
Having said that, I like his Philippine and Brazil trial strategy. There is a good chance that they could be successful because, as the longs all know, the drug works and has tremendous potential. Orders could start coming in from Philippine and change the complexion of the situation. I would welcome that.
But if the Company had management with significant successful drug development experience, successful execution could come a lot sooner for Cytodyn.
I view Mr. Rosenbaum's efforts as a large positive. At minimum, it will encourage soul searching by current management for ways to improve. Either way, longs can benefit."
13
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Top 5 Most Recently Viewed Articles
Geron Corporation Revamps Leadership to Enhance Growth Foster City, CA — Geron Corporation (Nasdaq: GERN), recognized for its commitment to transforming the lives of patients coping with blood cancer, has unveiled a series of executive changes aimed at fine-tuning its leadership to better reflect its ambitious strategic objectives. Among these changes, Dr. Andrew...
Continue Reading
GreenTree Hospitality Group Declares Cash Dividend GreenTree Hospitality Group Ltd. (NYSE: GHG), a prominent hospitality management company based in China, has recently made headlines by announcing a cash dividend of US$0.06 per ordinary share. This decision was approved by the board of directors, marking a significant commitment to rewarding its shareholders. Dividend...
Continue Reading
Nurix Therapeutics Welcomes Anil Kapur to Its Board Nurix Therapeutics, Inc. (NASDAQ: NRIX), a company dedicated to advancing therapies for cancer and inflammatory diseases, is thrilled to announce the addition of Anil Kapur to its board of directors. This appointment marks a significant step as the company prepares to enhance its leadership team. With an extensive...
Continue Reading
U.S. Postal Service Reports Financial Results The U.S. Postal Service has recently shared its financial results for the fiscal year. Notable accomplishments include reducing the controllable loss by $434 million compared to the previous fiscal year. Additionally, operating revenue increased by $1.4 billion, reaching a total of $79.5 billion. This growth is largely...
Continue Reading
Investment in Research Infrastructure through CFI OTTAWA, Ontario – The Government of Canada has recently unveiled a significant investment of nearly $4.4 million in research infrastructure through the Canada Foundation for Innovation (CFI) to support 17 Canada Research Chairs (CRCs) across 12 universities. This funding aims to strengthen Canada's position as a hub for...
Continue Reading